Navigation Links
MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
Date:2/7/2013

KENNESAW, Ga., Feb. 7, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTC: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the fourth quarter ended December 31, 2012, will be released before the opening of the market on Thursday, March 7, 2013. MiMedx will host a live broadcast of its fourth quarter conference call on Thursday, March 7, 2013 at 10:30 AM EST. A listen-only simulcast of the MiMedx Group conference call will be available online at the Company's website at www.mimedx.com or at www.earnings.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. The replay can also be found on the Company's website at www.mimedx.com or www.earnings.com.

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effectiv
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
2. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
3. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
4. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
5. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
6. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
7. MiMedx Group Announces Record Second Quarter Results
8. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
9. MiMedx Group Announces Record First Quarter Results
10. MiMedx Exceeds Revenue Goal for First Quarter of 2012
11. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Bellingham, Washington, USA, and Cardiff, UK (PRWEB) January 13, ... and photonics technology development leader with more than 20 ... international society for optics and photonics . Hainsey will ... “We are delighted to have Dr. Hainsey join SPIE ...
(Date:1/14/2014)... Rochester, NY (PRWEB) January 14, 2014 During ... is now known as “The Doctor’s Plague.” In this time ... their hands. This led, at times, to the death of ... staff today don’t know that they may be unwittingly transmitting ...
(Date:1/14/2014)... BioMedomics, Inc. , a Point of ... and novel disease specific POC tests, announced today that it ... total of $690,000. The investment is from private investors and ... group of private investors has significant successful experience in early ...
(Date:1/14/2014)... City, Panama (PRWEB) January 14, 2014 ... has received the county’s first clinical trial approval ... umbilical cord-derived mesenchymal stem cells (MSC) from the ... Review Board (IRB). , Rheumatoid Arthritis (RA) is ...
Breaking Biology Technology:Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3BioMedomics, Inc. Closes $690K Round of Financing 2Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board 2Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board 3
... OAB Drug in China, PLYMOUTH MEETING, Pa., ... BJGP ) ("BMP Sunstone" or the "Company") today,announced ... was officially accepted by China,s State Food & ... requirement prior to,pursuing a clinical trial and, ultimately, ...
... Programs Supported by a Grant from Otsuka ... America Pharmaceutical, Inc., ROCKVILLE, ... nonprofit organizations and one individual,as the recipients of the fifth annual ... the 2008 APF Annual Benefit in,Washington, D.C. Each organization or individual ...
... 6 Biomatrica, the leader in room,temperature biological sample ... as Vice President of Sales and Marketing.,Biomatrica,s interim Vice ... integral part of the company and will continue to ... Ms. Dowling brings fourteen years of sales and marketing ...
Cached Biology Technology:BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial 2BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing 2
(Date:4/23/2014)... pair of bioethics experts have added "playwright" to their ... in grappling with an onslaught of ethical issues as ... the human genome was first sequenced. , Until ... W. Bush have been performed for, and by, their ... conferences, meetings and in classrooms. With Oxford University ...
(Date:4/23/2014)... ripping open a dinner roll, a fuel cell catalyst ... hydrogen molecule. Now researchers have captured a view of ... its hydrogen feast. The view confirms previous hypotheses and ... better for alternative energy uses. , This study is ... hydrogen halves end up in the structure of a ...
(Date:4/23/2014)... source of a unique rhythmic sound, recorded for decades ... the Antarctic minke whale ( Balaenoptera bonaerensis ). First ... who thought it sounded like a duck, the bio-duck ... Southern Ocean, but its source has remained a mystery, ... of researchers deployed acoustic tags on two Antarctic minke ...
Breaking Biology News(10 mins):Bioethicists use theatrical narratives to bridge the gap between society and science 2Bioethicists use theatrical narratives to bridge the gap between society and science 3Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Scientists identify source of mysterious sound in the Southern Ocean 2Scientists identify source of mysterious sound in the Southern Ocean 3
... from the University of Copenhagen and the Technical University ... the US found that the bacterium Pseudomonas aeruginosa ... white blood cells preventing the bacteria being eliminated ... aeruginosa is responsible for many hospital-acquired infections and ...
... 2009 / b3c newswire /- PlatformQ , ... healthcare, education and energy markets, and LabRoots , a ... that Mark Vachon, the President and CEO for GE Healthcares ... Thursday November 19th at 2:00 PM. GE Healthcare ...
... Rockville, Md. (Oct. 30, 2009) A collaborative research team ... Australian Animal Health Laboratory and National Cancer Institute, a component ... forward in the development of an effective therapy against two ... results of this finding appear Oct. 30, 2009, in the ...
Cached Biology News:Bacteria 'launch a shield' to resist attack 2GE Healthcare President & CEO, Mark Vachon, to Present at BioConference Live 2USU scientists report major advance in human antibody therapy against deadly Nipah virus 2USU scientists report major advance in human antibody therapy against deadly Nipah virus 3
... developed specifically for the stabilization of ... plates/strips. Coating Stabilizer maintains the ... or protein antigen portion of the ... filtered at 0.2 microns., ,Contents: ...
... Novagen's HT96 Isothermal Block is an ... hold HT96 plates and to provide efficient ... plate. This new design of the HT96 ... offers an enhanced product design allowing for ...
Umbilical cord blood neutrophils, For immunohistochemistry (IHC)...
...
Biology Products: